4.7 Article

Leukocyte chemotactic factor 2: A novel renal amyloid protein

Journal

KIDNEY INTERNATIONAL
Volume 74, Issue 2, Pages 218-222

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ki.2008.152

Keywords

amyloid; kidney; nephrotic syndrome

Funding

  1. NCRR NIH HHS [RR-00750] Funding Source: Medline
  2. NIA NIH HHS [AG10133] Funding Source: Medline
  3. NIDDK NIH HHS [DK42111] Funding Source: Medline

Ask authors/readers for more resources

Renal amyloid deposits can often be seen in primary amyloidosis (immunoglobulin light chain disease) or in secondary forms such as reactive amyloidosis as well as in several hereditary forms where a variety of mutant proteins 'precipitate' as amyloid plaques. However, in rare cases, amyloidosis may be identified by renal biopsy, but no definitive diagnosis could be made. We have isolated amyloid fibrils from such a case in which the patient presented with nephrotic syndrome and subsequent azotemia requiring hemodialysis. Evaluation for amyloid deposition in other organ systems was negative and immunohistochemical analysis of the kidney deposits for known contributing proteins was unrevealing. Biochemical analysis of the fibrils identified a new amyloid subunit protein, leukocyte chemotactic factor 2, originally identified as a possible chemotactic and growth factor. A monoclonal antibody to this protein reacted specifically with the amyloid deposits in the glomeruli and interstitium by immunohistochemistry. This study emphasizes the importance of biochemical characterization of amyloid present in renal biopsies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available